Full name
V-MED BADANIA I ROZWÓJ SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
56.10.A - Restaurants and other eating places
62.01.Z - Computer programming activities
71.20.B - Other technical testing and analysis
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | -0,3 | -0,2 | 27,9 |
EBITDA | 0 | -0,3 | -0,2 | 35,4 |
Short time liabilities | 0 | 0,4 | 0,7 | 70,1 |
Equity capital | 0 | -0,3 | -0,3 | -20,9 |
Operating profit (EBIT) | 0 | -0,3 | -0,2 | 30,3 |
Assets | 0 | 0,1 | 0,3 | 194,5 |
Net profit (loss) | 0 | -0,3 | -0,2 | 27,9 |
Cash | 0 | 0,1 | 0 | -46,2 |
Net income from sale | 0 | 0,9 | 1,7 | 90,5 |
Liabilities and provisions for liabilities | 0 | 0,4 | 0,7 | 70,1 |
Working assets | 0 | 0,1 | 0,2 | 106,9 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 35 | 113,8 | 67,9 | -45,9 |
Equity capital to total assets | 95,9 | -252,9 | -103,8 | 149,1 |
Gross profit margin | 82,2 | -34,7 | -13,1 | 21,6 |
EBITDA Margin | 82,2 | -34,6 | -11,7 | 22,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 33 | 155 | 138 | -17 |
Current financial liquidity indicator | 24.297597885131836 | 0.2798202931880951 | 0.3403623402118683 | 0 |
Net dept to EBITDA | -1.4946002960205078 | -0.2557724416255951 | 0.16005124151706696 | 0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane